Breast Cancer Coverage From Every Angle
Editor:
William J. Gradishar, MD
Advertisement
Advertisement

Ongoing CE Activities

14th Annual School of Breast Oncology® Online
2017 NCCN Case Manager and Medical Director Program: Updates in the Management of Breast Cancer
34th Annual Miami Breast Cancer Conference® Clinical Case Vignette Series™
Adding Evidence to Front-Line Therapy of Hormone Receptor–Positive Breast Cancer (login required)
Assisting Community-Based Oncologists and Surgeons in Making Treatment Decisions for Patients with ER-Positive, HER2-Negative Early Breast Cancer
NCCN 2018 Congress Webinar Series: Breast Cancer – Barriers to the Coordination of Cancer Care
NCCN 2018 Congress Webinar Series: Breast Cancer – Surveillance of Patients With Early Stage and Advanced Disease
CDK 4/6 Inhibition in Breast Cancer: Self-Study Module II
CDK 4/6 Inhibition in Breast Cancer: Self-Study Module I
CDK4/6 Inhibitors: Moving Beyond the Breast Cancer Setting
Cases from the Community: Clinical Investigators Provide Their Perspectives on Actual Breast Cancer Cases and the Implications of Emerging Research
Community Practice Connections™: CDK4/6 Inhibitors With the Experts: The Role of Emerging Agents for the Management of Metastatic Breast Cancer
Consensus or Controversy, Issue 2: Clinical Investigators Provide Their Perspectives on Controversial Issues in the Management of HER2-Positive Breast Cancer (login required)
Data + Perspectives: Clinical Investigators Explore the Emerging Role of PARP Inhibition in the Management of Breast Cancer
Evolving Standards in HER2-Targeted Adjuvant Therapy (login required)
Hormone Receptor-Positive Advanced Breast Cancer: Challenges and New Treatment Options
Hormone Receptor-Positive Advanced Breast Cancer: Will ESR1 Have a Role? (login required)
Clinical Strategies for Incorporating Immunotherapy in Advanced Breast Cancer: Insights for Surgeons and Oncologists
Male Breast Cancer as a Second Primary Cancer: Increased Risk Following Lymphoma
Management of HR-Positive Advanced Breast Cancer: Is There a Best Sequence? (login required)
Medical Crossfire®: Establishing the Role of Predictive Biomarkers and Testing Strategies for Breast Cancer Management
Medical Crossfire®: Expert Perspectives on the Emerging Role of CDK4/6 Inhibitors for the Management of Metastatic Breast Cancer
NCCN Continuing Education in Breast Cancer
Oncology Grand Rounds Series: Part 3 — Breast Cancer: A satellite symposium held at the 2017 ONS Annual Congress
Oncology Grand Rounds: Breast Cancer
Beyond the Guidelines: Investigator Perspectives on Current Clinical Issues and Ongoing Research in the Management of Early and Advanced Breast Cancer
Consensus or Controversy? Clinical Investigators Provide Perspectives on Practical Issues and Ongoing Research Related to the Management of Breast Cancer
Predictors of Disruptions in Breast Cancer Care for Individuals with Schizophrenia
Significance and Relevance of Recent Data Sets and Publications in the Management of Breast Cancer
Recorded Presentations From the NCCN 2017 Congress Webinar Series: Breast Cancer
Response to PD-L1 Drug Boosts Survival in TNBC
Taxane-Based Tx May Put Breast Ca Patients Off Balance
Data + Perspectives: Biologic Basis and Available Clinical Research Underlying the Protocol and Nonresearch Use of PARP Inhibition in Patients with Ovarian and Breast Cancer
Virtual Molecular Tumor Board - A Webcast Series Exploring the Role of Molecular Profiling in Metastatic Breast Cancer (login required)
Virtual Patient Simulation: Case Studies in Early Stage HER2+ Breast Cancer (login required)
What Would You Do? Managing HR-Positive Advanced Breast Cancer
Year in Review: Proceedings from the Multitumor Regional Symposium Focused on the Application of Emerging Research Information to the Care of Patients with Common Cancers
Copyright © 2019 National Comprehensive Cancer Network, All Rights Reserved
By continuing to browse this site you permit us and our partners to place identification cookies on your browser and agree to our use of cookies to identify you for marketing. Read our Privacy Policy to learn more.